[Potentialities of MR tomography in monitoring the therapy of malignant bone tumors].
The value of MRI as a method for controlling treatment quantitatively was studied in four osteosarcomas and one Ewing sarcoma. Histologically proven change resulting from chemotherapy (2 patients) correlated with a significant increase in T2 of tumour tissue. In three other patients who did not respond to therapy, no change could be demonstrated. MRI appears to be valuable as a non-invasive method for monitoring treatment.
Just
M
M
Fachbereich Kernspintomographie, Deutsche Klinik für Diagnostik, Wiesbaden.
Gutjahr
P
P
Higer
H P
HP
Störkel
S
S
Rudigier
J
J
Ritter
G
G
Pfannenstiel
P
P
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D012516:Osteosarcoma / Q000175:diagnosis / Q000188:drug therapy*; D012512:Sarcoma, Ewing / Q000175:diagnosis / Q000188:drug therapy*
Möglichkeiten der MR-Tomographie in der Therapiekontrolle maligner Knochentumoren.